Literature DB >> 15355896

N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.

Keiji Yoshinaga1, Hiroshi Inoue, Tohru Utsunomiya, Hideto Sonoda, Takaaki Masuda, Koshi Mimori, Yoichi Tanaka, Masaki Mori.   

Abstract

PURPOSE: Activin A is a member of the transforming growth factor beta superfamily and plays an important role in the differentiation of embryonic stem cells. We have reported previously that the expression of activin A is associated with lymph node metastasis in esophageal cancer, and our purpose in the current work is to clarify the molecular mechanism of the aggressive behavior of tumors that have high activin A expression. EXPERIMENTAL
DESIGN: We have compared the gene expression profiles of human esophageal carcinoma cell lines that were stably transfected with activin beta A, which is a subunit of activin A, with those of control human esophageal carcinoma cell lines, using a cDNA microarray.
RESULTS: We found that the expression level of neuronal cadherin (N-cadherin) was higher in the transfectants than in the control cells. N-cadherin was located on the cell surface of the transfectants, irrespective of the expression of epithelial cadherin (E-cadherin), and the expression of N-cadherin mRNA was significantly associated with that of activin beta A mRNA in clinical samples of esophageal carcinoma (n = 51; r = 0.855). A clinicopathologic analysis suggested that expression of N-cadherin mRNA was associated with the depth of tumor wall invasion, and a group of patients with high expression of N-cadherin mRNA showed a significantly poorer prognosis than a group of patients with low N-cadherin expression (P = 0.046).
CONCLUSIONS: These results indicate that activin A might mediate the expression of N-cadherin and that this may be associated with depth of invasion and poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355896     DOI: 10.1158/1078-0432.CCR-03-0262

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  24 in total

1.  Loss of ACVRIB leads to increased squamous cell carcinoma aggressiveness through alterations in cell-cell and cell-matrix adhesion proteins.

Authors:  Holli A Loomans; Shanna A Arnold; Kate Hebron; Chase J Taylor; Andries Zijlstra; Claudia D Andl
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

Review 2.  The role of activin in mammary gland development and oncogenesis.

Authors:  Karen A Dunphy; Alan L Schneyer; Mary J Hagen; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-04-08       Impact factor: 2.673

3.  Clinical Significance of INHBA Gene Expression in Patients with Gastric Cancer who Receive Curative Resection Followed by Adjuvant S-1 Chemotherapy.

Authors:  Yusuke Katayama; Takashi Oshima; Kentaro Sakamaki; Toru Aoyama; Tsutomu Sato; Katsuhiko Masudo; Manabu Shiozawa; Takaki Yoshikawa; Yasushi Rino; Toshio Imada; Munetaka Masuda
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

4.  Reduced MTA1 expression by RNAi inhibits in vitro invasion and migration of esophageal squamous cell carcinoma cell line.

Authors:  Haili Qian; Ning Lu; Liyan Xue; Xiao Liang; Xueyan Zhang; Ming Fu; Yongqiang Xie; Qimin Zhan; Zhihua Liu; Chen Lin
Journal:  Clin Exp Metastasis       Date:  2006-05-16       Impact factor: 5.150

Review 5.  Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression.

Authors:  Georgia Agiostratidou; James Hulit; Greg R Phillips; Rachel B Hazan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-09       Impact factor: 2.673

6.  N-cadherin levels in endothelial cells are regulated by monolayer maturity and p120 availability.

Authors:  Deana M Ferreri; Fred L Minnear; Taofei Yin; Andrew P Kowalczyk; Peter A Vincent
Journal:  Cell Commun Adhes       Date:  2008-11

7.  Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma.

Authors:  Kerem M Senses; Mehdi Ghasemi; Muhammad W Akbar; Murat Isbilen; Anna L Fallacara; Shoshana Frankenburg; Silvia Schenone; Michal Lotem; Maurizio Botta; Ali O Gure
Journal:  Medchemcomm       Date:  2016-10-27       Impact factor: 3.597

8.  Identification of proteins involved in neural progenitor cell targeting of gliomas.

Authors:  Karin Staflin; Thole Zuchner; Gabriella Honeth; Anna Darabi; Cecilia Lundberg
Journal:  BMC Cancer       Date:  2009-06-26       Impact factor: 4.430

9.  Establishment of a TGFβ-induced post-transcriptional EMT gene signature.

Authors:  George S Hussey; Laura A Link; Andrew S Brown; Breege V Howley; Arindam Chaudhury; Philip H Howe
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma.

Authors:  Walid Abushahba; Oyenike O Olabisi; Byeong-Seon Jeong; Rajeev K Boregowda; Yu Wen; Fang Liu; James S Goydos; Ahmed Lasfar; Karine A Cohen-Solal
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.